Aripiprazole: pharmacodynamics of a dopamine partial agonist for the treatment of schizophrenia. [electronic resource]
Producer: 20060524Description: S21-5 p. digitalISSN:- 0176-3679
- Antipsychotic Agents -- adverse effects
- Aripiprazole
- Cerebral Cortex -- drug effects
- Corpus Striatum -- drug effects
- Dopamine Agonists -- adverse effects
- Humans
- Limbic System -- drug effects
- Mesencephalon -- drug effects
- Neural Pathways -- drug effects
- Piperazines -- adverse effects
- Quinolones -- adverse effects
- Receptors, Dopamine D2 -- agonists
- Schizophrenia -- diagnosis
- Schizophrenic Psychology
- Serotonin 5-HT2 Receptor Antagonists
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.